Marksans Pharma Limited (NSE:MARKSANS)
India · Delayed Price · Currency is INR 347.15
+14.20 (4.26%)
Sep 23, 2026, 3:29 PM IST
Marksans Pharma Market Cap
Marksans Pharma has a market cap or net worth of 157.52 billion as of September 23, 2026. Its market cap has increased by 99.48% in one year.
Market Cap
157.52B
Enterprise Value
151.34B
Revenue
31.72B
Ranking
n/a
PE Ratio
30.50
Stock Price
347.15
ChartMarket Cap Chart
Since December 13, 2006, Marksans Pharma's market cap has increased from 3.65B to 157.52B, an increase of 4,213.76%. That is a compound annual growth rate of 20.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 157.52B | 92.80% |
| Dec 31, 2025 | 81.70B | -39.22% |
| Dec 31, 2024 | 134.43B | 84.14% |
| Dec 29, 2023 | 73.00B | 210.96% |
| Dec 30, 2022 | 23.48B | -4.66% |
| Dec 31, 2021 | 24.63B | -0.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.48T |
| Divi's Laboratories | 2.50T |
| Apollo Hospitals Enterprise | 1.28T |
| Lenskart Solutions | 1.23T |
| Concord Biotech | 165.23B |
| Vijaya Diagnostic Centre | 160.41B |
| Dr. Agarwal's Health Care | 155.42B |
| Syngene International | 153.33B |